Biosyntia

BiotechnologySeries BCopenhagen, Denmarkbiosyntia.com

Latest round

Series B

Last raised

Sep 2022

Total raised

$22M

Investors

6

About Biosyntia

Founded in 2012 in Copenhagen, Denmark, Biosyntia ApS specializes in the development of natural nutritional products.Biosyntia ApS specializes in developing innovative nutritional products that leverage natural ingredients to address specific health needs. Their core offerings include BioB7 ForskoPro, which supports hair health, and CitriVive, alongside the skin health formulation eraGlow. These products utilize unique technology to provide natural alternatives for consumers seeking effective solutions in personal care and nutritional support. The company targets a range of customers, including health-conscious individuals and beauty product retailers, primarily focusing on markets in Europe, North America, and select areas in Asia.Biosyntia ApS generates revenue through a combination of direct-to-consumer sales and partnerships with retailers and wholesalers. The company's transaction structure is designed to facilitate smooth engagement with its client base, which includes both individual consumers and commercial partners. Revenue streams are derived from sales of their flagship products, such as BioB7 ForskoPro and CitriVive, focusing on subscription models or bulk purchasing agreements for larger retailers. Pricing strategies are aligned with market expectations, providing competitive rates that reflect the quality and efficacy of their products.Biosyntia ApS plans to launch new products in the upcoming year to expand its product lineup, specifically targeting launches in late 2024. The company aims to penetrate new markets in Asia and North America, with efforts to establish a stronger presence by 2025.000 mn, will be utilized to support these product launches as well as to enhance marketing efforts and operational capacity to reach the targeted geographic expansion.

Who invested in Biosyntia

6 investors across 3 rounds

See all investors in Biosyntia

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Sep 30, 2022

    Amount

    $5.9M

    Investors

    Locked

  2. Series B

    Jul 6, 2022

    Amount

    $12M

    Investors

    Locked

  3. Series A

    May 23, 2018

    Amount

    $4.7M

    Investors

    Locked

Questions about Biosyntia

Who invested in Biosyntia?

Biosyntia has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Biosyntia raised?

Biosyntia has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Biosyntia last raise money?

Biosyntia's most recent round on record is a Series B, in Sep 2022.

What does Biosyntia do?

Founded in 2012 in Copenhagen, Denmark, Biosyntia ApS specializes in the development of natural nutritional products.

Where is Biosyntia headquartered?

Biosyntia is headquartered in Copenhagen, Denmark.

Which VCs invest in companies like Biosyntia?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Biosyntia's stage. Their profiles are linked below.

Raising like Biosyntia? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.